400 related articles for article (PubMed ID: 9253362)
41. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor.
Wilson DM; Ceda GP; Bostwick DG; Webber RJ; Minkoff JR; Pont A; Hintz RL; Bensch KG; Kraemer FB; Rosenfeld RG
J Clin Endocrinol Metab; 1984 Nov; 59(5):1002-5. PubMed ID: 6090497
[TBL] [Abstract][Full Text] [Related]
42. Somatotroph recruitment by glucocorticoids involves induction of growth hormone gene expression and secretagogue responsiveness.
Porter TE; Dean CE; Piper MM; Medvedev KL; Ghavam S; Sandor J
J Endocrinol; 2001 Jun; 169(3):499-509. PubMed ID: 11375120
[TBL] [Abstract][Full Text] [Related]
43. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
Felix I; Asa SL; Kovacs K; Horvath E; Smyth HS
Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
[TBL] [Abstract][Full Text] [Related]
44. Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome.
Ramsay JA; Kovacs K; Asa SL; Pike MJ; Thorner MO
Cancer; 1988 Jul; 62(2):445-50. PubMed ID: 2898285
[TBL] [Abstract][Full Text] [Related]
45. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
[TBL] [Abstract][Full Text] [Related]
46. Pituitary gland in hypothyroidism. Histologic and immunocytologic study.
Scheithauer BW; Kovacs K; Randall RV; Ryan N
Arch Pathol Lab Med; 1985 Jun; 109(6):499-504. PubMed ID: 2986571
[TBL] [Abstract][Full Text] [Related]
47. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.
Garby L; Caron P; Claustrat F; Chanson P; Tabarin A; Rohmer V; Arnault G; Bonnet F; Chabre O; Christin-Maitre S; du-Boullay H; Murat A; Nakib I; Sadoul JL; Sassolas G; Claustrat B; Raverot G; Borson-Chazot F;
J Clin Endocrinol Metab; 2012 Jun; 97(6):2093-104. PubMed ID: 22442262
[TBL] [Abstract][Full Text] [Related]
48. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
[TBL] [Abstract][Full Text] [Related]
49. Pituitary adenoma producing growth hormone and adrenocorticotropin: a histological, immunocytochemical, electron microscopic, and in situ hybridization study. Case report.
Kovacs K; Horvath E; Stefaneanu L; Bilbao J; Singer W; Muller PJ; Thapar K; Stone E
J Neurosurg; 1998 Jun; 88(6):1111-5. PubMed ID: 9609310
[TBL] [Abstract][Full Text] [Related]
50. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.
Bertherat J; Timsit J; Bluet-Pajot MT; Mercadier JJ; Gourdji D; Kordon C; Epelbaum J
J Clin Invest; 1993 Apr; 91(4):1783-91. PubMed ID: 8097209
[TBL] [Abstract][Full Text] [Related]
51. Acromegaly caused by growth hormone releasing hormone (GHRH) secreting tumor in multiple endocrine neoplasia (MEN-1).
Saleem TF; Santhanam P; Hamoudeh E; Hassan T; Faiz S
W V Med J; 2012; 108(2):26-30. PubMed ID: 22655432
[TBL] [Abstract][Full Text] [Related]
52. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
53. Detection of gonadotropin-releasing hormone receptor in normal human pituitary cells and pituitary adenomas using immunohistochemistry.
La Rosa S; Celato N; Uccella S; Capella C
Virchows Arch; 2000 Sep; 437(3):264-9. PubMed ID: 11037346
[TBL] [Abstract][Full Text] [Related]
54. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
55. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM
Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237
[TBL] [Abstract][Full Text] [Related]
56. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors.
Ho PJ; Jaffe CA; Friberg RD; Chandler WF; Barkan AL
J Clin Endocrinol Metab; 1994 Jun; 78(6):1403-10. PubMed ID: 7911124
[TBL] [Abstract][Full Text] [Related]
57. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
[TBL] [Abstract][Full Text] [Related]
58. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone.
Asa SL; Kovacs K; Stefaneanu L; Horvath E; Billestrup N; Gonzalez-Manchon C; Vale W
Endocrinology; 1992 Nov; 131(5):2083-9. PubMed ID: 1425411
[TBL] [Abstract][Full Text] [Related]
59. Regulation of the pituitary-specific transcription factor GHF-1/Pit-1 messenger ribonucleic acid levels by growth hormone-secretagogues in rat anterior pituitary cells in monolayer culture.
Soto JL; Castrillo JL; Dominguez F; Dieguez C
Endocrinology; 1995 Sep; 136(9):3863-70. PubMed ID: 7649093
[TBL] [Abstract][Full Text] [Related]
60. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
